Research
Adherence
Significant initial weight loss (decrease in BMI) is a strong predictor of high adherence to liraglutide treatment.
If you experience significant weight loss in the first few months of liraglutide treatment, you are much more likely to stick with the medication long-term. This positive feedback loop is a key factor in maintaining adherence.
GoodSupportsHIGH confidence
A greater decrease in BMI was associated with improved adherence (OR 1.251, 95% CI 1.167–1.341; p < 0.001).
Why this rating
Statistically significant association in a large cohort.
Source
Adherence to liraglutide among individuals with overweight and obesity: Patient characteristics and clinical measures
Amit Guy et al. · Diabetes Obesity and Metabolism · 2024
DOI 10.1111/dom.15436
cohort · n=1890Cited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Adherence to liraglutide 3.0 mg for obesity treatment is extremely low (84.9% of patients exhibit low adherence), with only 15.1% achieving high adherence (PDC ≥80%) after 6 months.Good
- Higher socioeconomic status and non-smoking status are significantly associated with higher adherence to liraglutide treatment.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →